MEDIVATION, INC.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | $573,000 | −$8.5M | −$22.2M | −$26.2M | −$42.9M | −$32.7M |
| Net income | −$3.1M | −$13.7M | −$42.6M | −$41.3M | −$38.8M | −$34.0M |
| Total assets | $1.43B | $911.6M | $392.6M | $371.9M | $175.1M | $239.6M |
| Total liabilities | $558.9M | $462.3M | $315.7M | $298.2M | $173.8M | $231.9M |
| Equity | $872.7M | $449.3M | $76.9M | $73.6M | $1.3M | $7.7M |
| EPS (diluted) | $-0.02 | $-0.09 | $-0.28 | $-0.56 | — | — |
| Shares out. | 78.2M | 76.3M | 74.8M | 36.0M | 71.5M | 34.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- —
- Return on equity
- −0.4%
- Return on assets
- −0.2%
- Return on capital (ROCE)
- 0.0%
- Liabilities / assets
- 39.0%
- Debt / equity
- 0.64×
- Book value / share
- $11.15
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- 3.75safe
- Accruals / assets
- −15.6%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 16, 2004
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2004
- NT 10-Qmissed a reporting deadline ↗May 17, 2004
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2004
- NT 10-Qmissed a reporting deadline ↗Aug 18, 2003
- NT 10-Qmissed a reporting deadline ↗May 16, 2003
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Yarno Wendy LDirector | Sep 28, 2016 | U | 32,742 | — |
| Yang Tseli LilyOfficer — VP, Finance and Accounting | Sep 28, 2016 | U | 541 | — |
| Vernon W AnthonyDirector | Sep 28, 2016 | U | 17,742 | — |
| Svoronos DawnDirector | Sep 28, 2016 | U | 21,206 | — |
| Powell Andrew Kenneth WilliamOfficer — SVP, General Counsel & Crp Sec | Sep 28, 2016 | U | 5,597 | — |
| Mccourt MarionOfficer — Chief Operating Officer | Sep 28, 2016 | U | 541 | — |
| Machado PatrickDirector | Sep 28, 2016 | U | 70,792 | — |
| King Michael LDirector | Sep 28, 2016 | U | 2,972 | — |
| Jarrett JenniferOfficer — Chief Financial Officer | Sep 28, 2016 | D | 29,971 | — |
| Hung DavidOfficer — President and CEO | Sep 28, 2016 | U | 1.5M | — |
| Hirmand MohammadOfficer — Interim Chief Medical Officer | Sep 28, 2016 | U | 39,068 | — |
| Falberg Kathryn EDirector | Sep 28, 2016 | U | 32,742 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 28, 2016
- Director / officer changeSep 2, 2016
- Entered a material agreement · Modified shareholder rights · Director / officer change · Regulation FD disclosureAug 22, 2016
- Results of operationsAug 9, 2016
- Regulation FD disclosureJul 29, 2016
- Regulation FD disclosureJul 6, 2016
- Other material eventJul 5, 2016
- Director / officer change · Shareholder voteJun 27, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BOct 11, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- 4FORM 4 SUBMISSIONSep 30, 2016
- S-8 POSSep 28, 2016
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.